Will UFMG's vaccine against COVID enter human trials in Brazil in 2021?
Market Rules
The Federal University of Minas Gerais (UFMG) has started the development of a vaccine against COVID-19 completely designed and manufactured in Brazil. The research team is preparing to launch clinical studies in animals and then start testing on humans.
The team aims to carry out tests on humans later in 2021.
If Brazil starts testing UFMG's vaccine against COVID-19 in humans on or before December 31, 2021, this market will be resolved as "Yes"